teneligliptin

AssetSmall moleculeAlso Teneli, Teneligliptin Hydrobromide

DPP-4 inhibitor improving glycemic control

Stage
Phase 3
Modality
Small molecule
Target
Insulin/IGF-1 signalling
Indications
1
Trials
94
Developers
2

Indications

1
  • Targets and what it contains4
  • Owner and partners2
  • Trials94
  • Evidence for its targets4
  • Competitors12
  • Aging relevance1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 5 sources

Assets